ChromaDex Corp. has launched Tru Niagen Pro 500, the largest daily serving of its patented nicotinamide riboside.
Photo © iStockphoto.com/Saklakova
ChromaDex Corp. (Los Angeles, CA) has launched Tru Niagen Pro 500, the largest daily serving of its patented nicotinamide riboside (NR). The product will be exclusively available through licensed healthcare practitioners in the United States.
“This new product will allow practitioners to provide a unique product to their patients who want more energy and improved cellular health,” said ChromaDex CEO Rob Fried, in a press release.
“We are pleased to launch this new product exclusively through the healthcare practitioner channel,” added ChromaDex chief scientific officer Matthew Roberts, PhD. “This new product launch marks a major milestone in a year already characterized by several new significant scientific publications, human clinical data, and regulatory approvals around the world for ChromaDex.”
Senate Committee has released the text of 2024 Farm Bill, with changes to hemp regulations
November 19th 2024The U.S. Senate Committee on Agriculture, Nutrition, & Forestry has introduced the Rural Prosperity and Food Security Act, which will serve as the Senate’s draft for the 2024 Farm Bill.